FibroFind is a preclinical drug development powerhouse that provides its clients with knowledge exchange of current understanding in the field of fibrosis and chronic disease to help guide their drug development aspirations. Fibrofind designs and executes drug development studies with care, tailoring work to its clients' goals and building the foundations for clinical implementation of their products. Fibrofind has developed a technology that allows prolonged use of functional precision-cut slices of various human organs tissues applying our technology to the liver, kidney, and IPF lung PCS. With its PCS patented technology Fibrofind is able to keep human organ slices in an intact and active state for 7 days. We have optimized induction of fibrogenesis/fibrosis in normal PCS using a specific set of stimuli, which we are able to readily block using an inhibitor, this providing a positive control for any treatment that its clients may want us to test.